Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06986707 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Strain Counterstrain Technique and Graston Technqiue on Quadratus Lumborum Trigger Points

StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial completed
    • Eligibility criteria expanded, about 9 words
    • Secondary endpoints: details revised at 2 of 2 entries
    • Site details revised
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jun 10, 2025 to Jun 12, 2025
    • Site details revised
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Poor body mechanics and posture affects body positioning and stresses quadratus lumborum muscle which ultimately leads to myofascial trigger points in muscle. This study aims to compare the effects of Strain counterstrain technique and Graston technique on trigger points of quadratus lumborum in nonspecific low back patients. This study will be a randomized controlled trial and will be conducted in Riphah Rehabilitation Clinic Lahore and SPARC Physiotherapy Clinic Lahore. Non-probability convenient sampling will be used to collect the data. Sample size of 34 subjects with age group between 20-45 years will be taken. baseline and after 4 weeks. Data analysis will be done by SPSS version 25.
Trial Details
NCT Number NCT06986707
Lead Sponsor Riphah International University
Conditions
(from sponsor)		 Trigger Point Pain, Myofascial
Related terms Low Back Pain, Myofascial Pain Syndromes
Enrollment 34 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov